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Within living cells, mitochondria are considered relevant sources of reactive oxygen species (ROS) and are
exposed to reactive nitrogen species (RNS). During the last decade, accumulating evidence suggests
thatmitochondrial (dys)function, ROS/RNS levels, and aberrations inmitochondrial morphology are intercon-
nected, albeit in a cell- and context-dependent manner. Here it is hypothesized that ROS and RNS are
involved in the short-term regulation of mitochondrial morphology and function via non-transcriptional
pathways. We review the evidence for such a mechanism and propose that it allows homeostatic control
of mitochondrial function and morphology by redox signaling.Introduction
Mitochondria are motile organelles that are present in virtually
every mammalian cell and display a continuous cycle of fission
and fusion (Westermann, 2010; Chan, 2012; Birsa et al., 2013).
These mitochondrial dynamics are mediated by an extensive
protein machinery and, in combination with chemiosmosis-
related mitochondrial swelling/shrinking and removal of
damaged mitochondria by mitophagy, determine net mitochon-
drial morphology (Westermann, 2010; Twig and Shirihai, 2011;
Picard et al., 2013; Archer, 2013). At the structural level,
mitochondria consist of an outer membrane (MOM) and a
highly folded inner membrane (MIM), which protrudes into the
mitochondrial matrix compartment (cristae). The MIM and
MOM are separated by the mitochondrial intermembrane space
(IMS) and are partially connected via contact sites, involved in
cristae organization (Mannella et al., 2013; Pfanner et al.,
2014).Mitochondrial fission (Figure 1A) is guided by contact sites
between mitochondria and endoplasmic reticulum (ER) tubules
(Friedman et al., 2011) and executed by Dynamin-related protein
1 (Drp1), a cytosolic guanosine triphosphatase that is recruited
from the cytosol to the MOM (Lackner and Nunnari, 2010;
Chan, 2012). Currently, four adaptor proteins have been identi-
fied that mediate Drp1 recruitment (Otera et al., 2010; Chan,
2012; Loso´n et al., 2013): human fission protein 1 (hFis1), mito-
chondrial fission factor (Mff), and two mitochondrial elongation
factors (MIEF1/MiD51 and MIEF2/MiD49). Mitochondrial fusion
(Figure 1A) occurs by sequential merging of the MOM and MIM
(Mishra et al., 2014). This process is ATP-dependent, requires
a sufficiently negative trans-MIM electrical potential (Dc), and
is mediated by two mitofusins (Mfn1/Mfn2; MOM-fusion) and
the optic atrophy 1 protein OPA1 (MIM-fusion; Meeusen et al.,
2004; Frezza et al., 2006; Chan, 2012; Belenguer and Pellegrini,
2013; Boissan et al., 2014).
Mitochondria can display a large variety of shapes (Figure 1B),
ranging from ‘‘giant’’ spherical morphologies (Yoon et al., 2006)
to ‘‘hyperfused’’ reticular networks (Mitra et al., 2009). Evidence
was provided that changes inmitochondrial volume and/or (ultra)structure affect the kinetics of biochemical reactions and assem-
bly of protein supercomplexes in the mitochondrial matrix
(Lizana et al., 2008; Dieteren et al., 2011; Cogliati et al., 2013;
Mannella et al., 2013). Althoughmuch progress wasmade during
the last decade (e.g., Benard et al., 2007, 2013; Twig and
Shirihai, 2011; Chan, 2012; Picard et al., 2013; Archer, 2013;
Jose et al., 2013; Varikmaa et al., 2013; Rambold et al., 2015),
it is still unclear how the various mitochondrial morphologies
are mechanistically linked to mitochondrial functions. This might
relate to the fact that various fission and fusion proteins also have
roles outside of mitochondrial dynamics (e.g., Zorzano et al.,
2010; Schrader et al., 2012).
During the last decade, experimental strategies combining
live-cell microscopy and fluorescent reporter molecules were
developed to allow unbiased 2D and 3D quantification of mito-
chondrial morphology and statistical analysis (Figures 1C–1E;
reviewed in Tronstad et al., 2014). Quantitative analysis is crucial
to discriminate between mitochondrial phenotypes that ‘‘look’’
similar. For instance, visual inspection of mitochondrial micro-
scopy images might not always be suited to distinguish between
‘‘true’’ mitochondrial fragmentation (i.e., cleavage of mitochon-
drial tubules resulting in smaller mitochondria that are more
abundant) and ‘‘apparent’’ fragmentation (i.e., mitochondrial
tubules become smaller but mitochondrial number does not
increase). Assessing the continuity of the mitochondrial matrix
compartment is crucial to functionally understand the sharing
ofmitochondrial content such asmtDNA, tRNA,mRNA, proteins,
and small molecules such as ATP, ADP, and antioxidants.
Studies using Dc-sensitive reporter molecules revealed the
existence of equipotential mitochondrial ‘‘sub-networks,’’ sug-
gesting that matrix connectivity is not complete throughout mito-
chondrial filaments that appear continuous (Twig et al., 2008).
Matrix connectivity can be experimentally demonstrated in living
cells using photo-convertible proteins (Figure 1F; Gurskaya
et al., 2006), photobleaching strategies like FRAP (fluorescence
recovery after photobleaching) and FLIP (fluorescence loss in
photobleaching; e.g., Dieteren et al., 2011; Distelmaier et al.,Cell Metabolism 22, August 4, 2015 ª2015 Elsevier Inc. 207
A B
C D E
Spherical Fragmented Tubular Filamentous “Hyperfused”"Giant"
Cell division
Resting state?
Mitophagy permissive
Mitophagy preventing
Antioxidant sharing
Stress adapted
Exogenous H O2 2
BSO, FCCP
Damaged?
Apoptosis
Irreversible
Excessive ROS stress?
Antioxidant sharing
Metabolically active?
Physiology Stress, starvation?Stress, apoptosis?
Fission
Fusion
Drp1
Fis1
MIEF1/2
Mff
Mfn1/2
OPA1
F
t=2.541 s t=15.084 st=2.095 s
15 µm
G
15 µm
t=118 s t=122 st= 94 s
Low High
1 10 100 1000 10000
20
40
60
80
100
120
140
160
180
200
Area (pixels)
In
te
ns
ity
 (g
ra
yv
al
ue
)
Ar
ea AR F
Int
en
sit
y
D
es
cr
ip
to
r v
al
ue
0
2
4
6
8
100
200
15 µm
RAW COR LCS THF MED BIN MSK
Figure 1. Mitochondrial Dynamics and Its Analysis in Single Living Mammalian Cells
(A) Net mitochondrial morphology primarily results from the balance between fusion and fission. These processes are carried out by a set of eight core proteins
involved in fusion (Mfn1, Mfn2, OPA1) and fission (Drp1, Fis1, MIEF1/MiD51, MIEF2/MiD49, Mff).
(B) Mitochondria display various net morphologies depending on the cell type and/or metabolic state. In physiological (healthy) conditions (green), mitochondria
are motile and continuously fuse and divide. This state is associated with morphologies ranging between fragmented and filamentous. Stress conditions are
associated with giant/spherical (red) or hyperfused morphologies (blue) that appear to be linked to apoptosis induction and stress adaptation, respectively.
(C) Image processing scheme for quantification of mitochondrial morphology and function in healthy primary human skin fibroblasts (CT5120; Koopman et al.,
2008). Mitochondria are stained with TMRM (tetramethylrhodamine methyl ester) and imaged using epifluorescence microscopy. The resulting image (RAW) is
background corrected (COR), contrast optimized (LCS), spatially filtered using a top-hat filter (THF), median filtered (MED), and thresholded to yield a binary
image (BIN). Combining the BIN and COR image yields a masked image (MSK) suited for image quantification. The color coding reflects TMRM fluorescence
intensity ranging from low (blue) to high (red).
(D) Quantification of average mitochondrial morphology parameters for the 50 mitochondrial objects in (C) (MSK image). Depicted are mitochondrial area
(in pixels), aspect ratio (AR, a measure of mitochondrial length), formfactor (F, a combined measure of mitochondrial length and degree of branching), and
intensity (a measure of Dc). The error bars reflect the standard error of the mean (SEM).
(E) Relationship between mitochondrial area and TMRM fluorescence intensity. Each point represents an individual mitochondrial object.
(F) CT5120 cell expressing a mitochondria-targeted variant of the photo-convertible protein Dendra2. Upon pulse illumination with 405 nm light, the green-
emitting form of Dendra2 is converted into red-emitting Dendra2 (white box). The red-emitting Dendra2 will time-dependently redistribute throughout the
mitochondrial filaments if their matrix is continuous. Cells were transfected using a baculoviral expression system and imaged by confocal microscopy.
(G) CT5120 cell stained with TMRM. Extended illumination of the TMRM induced a synchronous Dc depolarization in a part of the mitochondrial network
(subnetwork), as reflected by the reversible loss of mitochondrial TMRM fluorescence. The latter is caused by photo-induced opening of the mitochondrial
permeability transition pore (mPTP) and suggests that the subnetwork is electrically coupled (i.e., possesses a continuous mitochondrial inner membrane). Cells
were imaged using epifluorescence microscopy.
Cell Metabolism
Perspective2015), or analysis of photo-induced reversible mitochondrial
permeability transition pore opening (Figure 1G; Ricchelli et al.,
2011; Blanchet et al., 2014).
Mitochondria generate ATP by oxidative phosphorylation
(OXPHOS; Mitchell, 1961) and participate in numerous other
metabolic pathways as well as energy sensing, making these
organelles hubs of metabolic signal integration (Frohman,
2010; Jose et al., 2013; Ho¨nscher et al., 2014). The OXPHOS208 Cell Metabolism 22, August 4, 2015 ª2015 Elsevier Inc.system is MIM embedded and abstracts electrons from NADH
(at complex I [CI]) and FADH2 (at complex II [CII]), which are
transported to complex III (CIII; by coenzyme Q10) and complex
IV (CIV; by cytochrome c). At the latter complex, electrons react
with molecular oxygen (O2), yielding H2O. Electron transport is
linked to proton (H+) efflux from the mitochondrial matrix (at CI,
CIII, and CIV), and the resulting proton-motive force (PMF) is
used to drive ATP generation by complex V (CV). The PMF
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which are not only essential for ATP production but also sustain
many other mitochondrial functions including metabolite/ion ex-
change and import of mitochondrial precursor proteins from the
cytosol (Szabo and Zoratti, 2014).
As a consequence of normal OXPHOS,mitochondria generate
reactive oxygen species (ROS) in a physiological range (Murphy,
2009). In human disease models, increased mitochondrial ROS
production has been linked to pathology induction (Yu et al.,
2006; Blanchet et al., 2011; Nakamura and Lipton, 2011; Naka-
mura et al., 2013; Qi et al., 2011; Halliwell and Gutteridge,
2012; Jose et al., 2013; Koopman et al., 2012, 2013; Niemann
et al., 2014). CI and CIII are most likely the major sources of
ROS in intact cells (Murphy, 2009). Under certain conditions
CII and other mitochondrial and cellular ROS sources can also
be relevant (Koopman et al., 2010; Brown and Borutaite, 2012;
Mailloux et al., 2013; Quinlan et al., 2013; Woolley et al., 2013).
The superoxide anion (O2
d) is the primary ROS generated and
is converted into hydrogen peroxide (H2O2) by superoxide dis-
mutases (SODs; Auche`re and Rusnak, 2002). The highly reactive
hydroxyl radical (dOH), generated via the Fenton reaction from
O2
d and H2O2, can initiate formation of lipid (Ld) and lipid per-
oxyl (LOOd) radicals. H2O2 is converted into H2O by enzymes
including peroxiredoxins, catalase (CAT), and glutathione perox-
idases (GPX). Proper functioning of these systems further re-
quires the action of various other enzymatic and non-enzymatic
systems (Koopman et al., 2010; Brown and Borutaite, 2012;
Mailloux et al., 2013; Quinlan et al., 2013; Woolley et al., 2013).
In the context of this review it is important to mention that mito-
chondria are exposed to the reactive nitrogen species (RNS)
nitric oxide (NOd) and that NOd can react with O2
d to form per-
oxynitrite (ONOO). This molecule can be converted into various
other reactive species including dOH (Valerio and Nisoli, 2015).
Coincident alterations in ROS/RNS levels and mitochondrial
morphofunction have been described in various experimental
studies (see next section), suggesting that there is a mechanistic
link between redox homeostasis and regulation of mitochondrial
morphology. Below, we first review the evidence for such a
connection and then focus on redox-induced posttranslational
modifications of mitochondrial fission/fusion proteins and their
binding partners. We conclude by proposing a working model
integrating mitochondrial redox homeostasis with mitochondrial
morphofunction.
Links between Redox Homeostasis and Mitochondrial
Morphology
Parallel changes in ROS/RNS levels and mitochondrial
morphology have been reported in many experimental studies.
For example, patient primary fibroblasts with a greatly reduced
CI activity display a fragmented mitochondrial phenotype and
highly increased ROS levels, whereas cells with a moderately
reduced CI activity display normal mitochondrial morphology
and moderately increased ROS levels (Koopman et al., 2007;
Blanchet et al., 2011). Also in fibroblasts, exogenous H2O2
addition stimulated ubiquitination of Mfn1/Mfn2 (but not of
OPA1 or hFis1) paralleled by mitochondrial fragmentation
(Rakovic et al., 2011). Conversely, lowering fibroblast ROS levels
by the antioxidant Trolox stimulated Mfn2-dependent mitochon-
drial filamentation and increased OXPHOS protein expressionand enzymatic activity (Distelmaier et al., 2012; Blanchet et al.,
2015). Exposing skeletal muscle myoblasts to exogenous H2O2
triggered Dc depolarization and stimulated mitochondrial frag-
mentation, suggesting that ROS-inducedmitochondrial depolar-
ization might be responsible for mitochondrial fragmentation
(Fan et al., 2010). In a Drosophila wound-healing model, high
ROS levels induced Drp1-mediatedmitochondrial fragmentation
involving the Rho effector ROCK, whereas low ROS levels pro-
moted mitochondrial filamentation (Muliyil and Narasimha,
2014). Cells devoid of Mfn1 or Mfn2 displayed a fragmented
mitochondrial morphology and increased ROS levels (Mun˜oz
et al., 2013). Conversely, genetic pro-fusion interventions
(inducing mitochondrial elongation) were associated with
reduced mitochondrial ROS production, whereas pro-fission in-
terventions (leading to mitochondrial fragmentation) stimulated
mitochondrial ROS production (Picard et al., 2013). During
hyperglycemic conditions, mitochondrial fragmentation was
required to allow increased ROS production (Yu et al., 2006).
However, although Drp1 overexpression induced mitochondrial
fragmentation in HeLa cells, it was not associated with increased
ROS levels (Distelmaier et al., 2012). OPA1 mutations in
Drosophila induced aberrations in mitochondrial morphology
and increased ROS production and susceptibility to oxidative
stressors (Tang et al., 2009), suggesting that mitochondrial fila-
mentation protects against oxidative stress.
Glutathione (GSH) plays a central role in ROS-induced redox
signaling and stress induction (Mailloux et al., 2013). In the
central nervous system (CNS), loss of ganglioside-induced
differentiation-associated protein 1 (GDAP1) is compensated
by the mitochondrial translocation of GDAP1L1 (a GDAP1
paralog). This recruitment is stimulated by elevated levels of
oxidized GSH (GSSG), suggesting that GDAP1-family members
can act as redox sensors during cell protection (Niemann et al.,
2014). In primary human fibroblasts, inhibition of GSH synthesis
by l-buthionine-(S,R)-sulphoximine (BSO, 12.5 mM, 72 hr) shifted
the cytosolic andmitochondrial thiol redox environment toward a
fully oxidized state (Verkaart et al., 2007). The latter was associ-
ated with a reduction in mitochondrial size (‘‘shrinkage’’; Distel-
maier et al., 2012), compatible with the proposed link in vivo
between oxidation of the mitochondrial matrix environment
and mitochondrial tubule shortening (Breckwoldt et al., 2014).
Overexpression of BOLA1, a mitochondrial protein that interacts
with glutaredoxin 5 (GLRX5), attenuated the BSO-induced ef-
fects on thiol redox state and preventedmitochondrial shrinkage
(Willems et al., 2013). In contrast, BSO treatment of HeLa cells
(100 mM, 24 hr) induced mitochondrial hyperfusion, which might
act as a transient protection against apoptosis and mitophagy
(Shutt et al., 2012). Mechanistically, the latter study provided
evidence that GSSG stimulates generation of disulfide-mediated
(Cys684) Mfn oligomers. The different effects of BSO in fibro-
blasts and HeLa cells suggest that the effects of GSH depletion
on mitochondrial morphology depend on BSO concentration,
incubation time, and/or cell type (Koopman et al., 2013).
Increasing NOd concentrations triggered a dose- and Drp1-
dependent increase in mitochondrial fragmentation (Cho et al.,
2009). Conversely, NOd scavenging stimulated mitochondrial
filamentation in human pulmonary arterial endothelial cells
(Lee et al., 2013). The above results suggest that increased
ROS/RNS levels are linked to a fragmented and (more)Cell Metabolism 22, August 4, 2015 ª2015 Elsevier Inc. 209
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context-dependent manner. Most of the experimental evidence
points to a mechanism in which low ROS/RNS levels do not
affect mitochondrial morphology and/or induce filamentation,
whereas too high ROS/RNS levels that cannot be appropriately
counterbalanced by the cell’s antioxidant defense system
induce mitochondrial fragmentation, swelling, and/or short-
ening. In this sense, evidence was provided that mild oxidative
stress triggers Drp1-dependent mitophagy (Frank et al., 2012).
It was proposed that the various mitochondrial structural pheno-
types reflect different metabolic and/or (patho)physiological
states (Westermann, 2010; Picard et al., 2013). However, it
is still not firmly established whether elongated or fused mito-
chondria perform bioenergetically ‘‘better’’ (or worse) than frag-
mented ones. In the next section, we discuss the theoretical and
empirical evidence linking redox homeostasis to mitochondrial
dynamics.
Coupling Mechanisms between Redox Homeostasis
and Mitochondrial Morphology
In principle, mitochondrial dynamics can be controlled by the
amount, activity, and localization of the fission/fusion proteins,
but also by the lipid composition of mitochondrial membranes
(see below). The role of mitochondrial motility and control ex-
erted at the level of protein processing/degradation, mRNA,
and transcription/translation are discussed elsewhere (e.g.,
Benard et al., 2007, 2013; Birsa et al., 2013; Jose et al., 2013;
Mishra and Chan, 2014). Here we primarily focus on non-
transcriptional regulation by redox-sensitive posttranslational
modifications (PTMs), which can occur at a relatively short time-
scale. To this end, we first generated an inventory of (predicted)
PTMs for Drp1, Mfn1, Mfn2, OPA1, hFis1, Mff, MIEF1/MiD51,
and MIEF2/MiD49 by integrating information from various online
databases and empirical studies (Figure 2). This highlighted
various PTMs (i.e., phosphorylation, S-nitrosylation, sumoyla-
tion, ubiquitination, tyrosine sulfation, and acetylation). Next,
we extended this inventory by also including known and pre-
dicted proteinaceous binding partners for Drp1, hFis1, Mfn1/2,
and OPA1 (Supplemental Information).
Of the core fission/fusion proteins only Drp1 (Cho et al., 2009)
and possibly OPA1 (Bossy et al., 2010) are posttranslationally
modified in a redox-sensitive manner by S-nitrosylation. In addi-
tion, several proteins that bind to the core fission/fusion proteins
contain redox-sensitive motifs (Table 1): amyloid-b (S-nitrosyla-
tion), CDK5 (S-nitrosylation), Parkin (S-nitrosylation), PKA/
AKAP1 (disulfide bond, nitration), Timm8a (disulfide bond), cas-
pase-3 (S-nitrosylation), paraplegin (nitration), ROMO1 (disulfide
bond), and JNK (S-nitrosylation). All of these modifications can
be induced by H2O2, NO
d, or ONOO, thereby functionally
affecting Drp1, OPA1, Mfn2, and mitochondrial structure
(Figure 3). The chemistry and biology regarding protein S-nitro-
sylation (SNO), disulfide bond formation, and nitration is dis-
cussed in detail elsewhere (Sacksteder et al., 2006; Nakamura
and Lipton, 2011; Halliwell and Gutteridge, 2012; Nakamura
et al., 2013; Bak andWeerapana, 2015; Valerio and Nisoli, 2015).
Redox Regulation of Drp1
NOd and amyloid-b peptide were demonstrated to induce
mitochondrial fragmentation in neurons (Barsoum et al., 2006;
Nakamura and Lipton, 2011). Evidence was provided that210 Cell Metabolism 22, August 4, 2015 ª2015 Elsevier Inc.NOd elevation increases the GTPase activity of Drp1 by S-nitro-
sylation of Cys644 in response to amyloid-b peptide (Cho et al.,
2009). It was proposed that formation of S-nitrosylated Drp1
(Drp1-SNO) induces Drp1 dimerization and increases GTPase
activity (Cho et al., 2009). S-nitrosylation-induced activation of
dynamins, including Drp1, was also observed in other studies
(see Nakamura and Lipton, 2011 and the references therein). In
contrast, another study suggested that Drp1-SNO does not
dimerize and displays no increased GTPase activity (Bossy
et al., 2010). Although these authors detected OPA1-SNO,
they did not observe significant differences in Drp1-SNO levels
between brains of age-matched normal and patients with Alz-
heimer’s (AD) or Parkinson’s disease (PD). Interestingly, experi-
mental evidence suggests that NOd production stimulates the
phosphorylation of Ser616, thereby increasing Drp1 activity
and MOM recruitment (Bossy et al., 2010). It was proposed
that NOd-induced Ser616 phosphorylation is mediated by
NOd-stimulated kinases. However, under physiological condi-
tions, Drp1 needs to exist in a non-oxidized form for NOd-
induced S-nitrosylation to occur. In this sense, Nakamura and
Lipton argued that artifactual Drp1 oxidation might have
occurred in the study of Bossy and coworkers (Nakamura and
Lipton, 2011). Amyloid-b production was triggered by mitochon-
dria-derived ROS using in vitro and in vivo models (Leuner et al.,
2012), leading to activation of Drp1 via stimulating S-nitrosyla-
tion (Cho et al., 2009). It was proposed that the ensuing mito-
chondrial fragmentation (co)contributes to mitochondrial
dysfunction induced by amyloid-b (Wang et al., 2008). Ser616
phosphorylation of Drp1 generally promotes mitochondrial
fission (e.g., Taguchi et al., 2007; Qi et al., 2011; Gan et al.,
2014). Remarkably, CDK5-induced phosphorylation of this
serine residue inhibits Drp1 and induces mitochondrial elonga-
tion during neuronal maturation under physiological conditions
(Cho et al., 2014). It was proposed that this effect was mediated
by CDK5-induced reduction of Drp1 oligomerization. Parkin is a
cytosolic E3 ubiquitin ligase involved in Drp1 ubiquitination and
its subsequent proteasome-dependent degradation (Wang
et al., 2011). S-nitrosylation inactivates Parkin, leading to
impaired Drp1 degradation and stimulation of mitochondrial
fragmentation (Chung et al., 2004; Lutz et al., 2009). PKA-medi-
ated Drp1 phosphorylation inhibits its fission promoting activity,
stimulating mitochondrial filamentation (Kim et al., 2011; Merrill
et al., 2011). The effect of PKA nitration is currently unknown.
Formation of a disulfide bond between the two regulatory sub-
units of PKA induces activation (Brennan et al., 2006). This
suggests that ROS-induced PKA-activation stimulates mito-
chondrial filamentation by inhibiting Drp1. Timm8a is released
from the IMS during apoptotic conditions and binds to cytosolic
Drp1 to promote its translocation to the MOM and thereby mito-
chondrial fragmentation (Arnoult et al., 2005). Timm8a is a
protein involved in mitochondrial protein import and contains a
disulfide bond that, in yeast, appears to be involved in forming
stabilizing intramolecular disulfide bonds important in the forma-
tion of the Tim8p-Tim13p complex (Curran et al., 2002). How
this is linked to Drp1 translocation is unclear. Although not
predicted to contain a redox-sensitive motif, PKCd stimulates
Ser616 phosphorylation of Drp1 and stimulates mitochondrial
fragmentation under conditions of oxidative stress, providing
a mechanism for ROS-induced mitochondrial fragmentation
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Figure 2. Domain Structure and Posttranslational Modifications of Core Mitochondrial Fission and Fusion Proteins in Humans
(A–H) Domain structure and observed/predicted posttranslational modifications (PTMs) of: (A) Drp1, (B) Mfn1, (C) Mfn2, (D) OPA1, (E) hFis1, (F) Mff, (G) MIEF1/
MiD51, and (H) MIEF2/MiD49. (+), phosphorylation; (), dephosphorylation; ADP, ADP binding site; CaN, calcineurin; CC, coiled-coil; DIM, dimerization domain;
Drp1, Drp1 interaction; GED, GTPase effector domain; GSK3b, glycogen synthase kinase 3 b; HR, heptad-repeat; LZ, leucine zipper; MTS, mitochondrial
targeting sequence; NAL, N6-acetyllysine; NAM, N-acetylmethionine; NO, nitric oxide; NT, nucleotidyltransferase domain; OL, O-linked glycosylation (GlcNac);
Olig., oligomerization domain; STyr, sulfotyrosine; T, transmembrane helix; TPR, tetratricopeptide repeat. Data were compiled from UnitprotKB (Homo sapiens;
http://www.uniprot.org) and dbPTM (http://dbptm.mbc.nctu.edu.tw): Drp1 (736 aa; O00429), Fis1 (152 aa; Q9Y3D6), Mff (342 aa; Q9GZY8), MIEF1/MiD51
(463 aa; Q9NQG6), MIEF2/MiD49 (454 aa; Q96C03), Mfn1 (741 aa; Q8IWA4), Mfn2 (757 aa; O95140), OPA1 (960 aa; O60313). Abbreviations and literature
references are provided in Supplemental Information.
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phatase PGAM5 is mediated by Kelch-like ECH-associated
protein 1 (KEAP1), which is an important redox stress-sensing
protein (Kanamaru et al., 2012). This suggests that the KEAP1-
PGAM5 complex regulates mitochondrial fission in a redox-
dependent manner.
Redox Regulation of OPA1
Proteolytic processing of OPA1 is an important means to control
its function (e.g., Song et al., 2007; Merkwirth et al., 2008; Ehses
et al., 2009; Chan, 2012; Quiro´s et al., 2012; Anand et al., 2014;
Mishra et al., 2014). Evidence was provided that OPA1 can be
S-nitrosylated (Bossy et al., 2010), although the functional effect
of this modification is currently unknown. N-terminal cleavage
of OPA1 by caspase-3 induces mitochondrial fragmentation
(Loucks et al., 2009). The activity of caspase-3 is inhibitedby S-nitrosylation and increased by denitrosylation during
apoptosis activation. This might allow OPA1-mediated regula-
tion of mitochondrial fragmentation by RNS species. Paraplegin
is a mitochondrial metalloprotease of the AAA family involved in
OPA1 processing (Ehses et al., 2009). Nitration of paraplegin
potentially affects its catalytic rate, protein-protein interactions,
and phosphotyrosine signaling pathways (Sacksteder et al.,
2006; Ehses et al., 2009). This might provide a link between
OPA1 processing/function and redox state. The ROMO1
(reactive oxygen species modulator 1) protein was recently
discovered as a regulator of cellular ROS generation and
redox-dependent modulator of mitochondrial fusion and cristae
morphology (Norton et al., 2014). This protein possesses two
conserved cysteines (Cys15 and Cys79) that form a redox-
sensing module. In its monomeric state, ROMO1 is required toCell Metabolism 22, August 4, 2015 ª2015 Elsevier Inc. 211
Table 1. Mechanistic Non-transcriptional Links between Redox Homeostasis and Mitochondrial Dynamics Proteins
Protein Interactor Function Redox Modification Reference
Drp1 and Interactors
Drp1 n.a. Core MOM fission protein. S-nitrosylation, which stimulates mitochondrial
fission. Possibly by enhancing Drp1 MOM
recruitment, increasing Drp1 GTPase activity,
stimulating Drp1 oligomer formation,
or increasing Drp1 phosphorylation at Ser616.
Cho et al., 2009;
Bossy et al., 2010
Amyloid-b Drp1 S-Nitrosylates Drp1 at Cys644
(activating) and possibly promotes
Drp1 phosphorylation at Ser616
(activating).
Disulfide bond. Extracellular binding and
reduction of copper (Cu) results in a
corresponding oxidation at Cys144 and
at Cys158 and the formation of a disulfide bond.
In vitro, the APP-Cu complex in the presence
of hydrogen peroxide results in an increased
production of amyloid-b-containing peptides.
Cho et al., 2009
CDK5 Drp1 Phosphorylates Drp1 at Ser616
and inhibits its activity, probably
by reducing Drp1 oligomerization.
S-nitrosylation activates CDK5. Qu et al., 2011;
Cho et al., 2014
Parkin Drp1 E3-ubiquitin ligase for Drp1. S-nitrosylation inhibits the ubiquitin E3 ligase
activity of Parkin. Loss of Parkin impairs Drp1
ubiquitinylation and increases Drp1-dependent
mitochondrial fragmentation.
Chung et al., 2004;
Lutz et al., 2009
PKA/AKAP1 Drp1 Mediates cAMP-dependent
phosphorylation of Drp1
(inactivation) at Ser637
(Ser656 in rat).
Disulfide bond (regulatory a and b subunit) and
nitration (regulatory b subunit). Formation of a
disulfide bond between the two regulatory
subunits of PKA induces activation.
Brennan et al., 2006;
Kim et al., 2011;
Merrill et al., 2011
PKCd Drp1 PKCd binds to Drp1 and
phosphorylates it (activation)
at Ser579 (Ser616 in human).
No redox motif. Drp1 phosphorylation is
associated with its translocation to MOM
under oxidative stress conditions.
Qi et al., 2011
Timm8a Drp1 Binds to cytosolic Drp1 when released
from the IMS during apoptosis and
promotes Drp1 transition to the MOM
and mitochondrial fragmentation.
Disulfide bond. Effect unknown. Arnoult et al., 2005
OPA1 and Interactors
OPA1 n.a. Core MIM fusion protein. S-nitrosylation (possibly), the effect of which
is unknown.
Bossy et al., 2010
Caspase-3 OPA1 N-terminal cleavage of OPA1 by
caspase-3 leads to mitochondrial
fragmentation.
S-nitrosylation. Caspase-3 is S-nitrosylated
on its catalytic site Cys in unstimulated human
cell lines and denitrosylated upon activation
of the Fas apoptotic pathway, associated
with an increase in intracellular caspase activity.
Loucks et al., 2009
Paraplegin OPA1 Involved in OPA1 processing.
Interacts with AFG3L2; the interaction
is required for the efficient assembly
of mitochondrial CI.
Nitration. Effect unknown. Potentially affecting
catalytic rate, protein-protein interactions and
phosphotyrosine signaling pathways.
Ehses et al., 2009;
Sacksteder et al., 2006
ROMO1 OPA1 Monomeric ROMO1 is required to
maintain mitochondrial fusion.
Disulfide bond (intermolecular). ROMO1 is
inactivated by GSH-dependent disulfide bond
formation in oxidizing environments leading
to OPA1 cleavage and cristae shape alteration.
Norton et al., 2014
Mitofusin Interactors
JNK Mfn2 Phosphorylates Mfn2 at Ser27,
leading to recruitment of ubiquitin
ligase (E3) Huwe1/Mule/ARF-BP1/
HectH9/E3Histone/Lasu1 to Mfn2
and ubiquitin-mediated proteasomal
Mfn2 degradation.
S-nitrosylation (JNK1, JNK3). S-nitrosylation
of JNK1 and JNK3 inhibits their activity.
Park et al., 2000;
Pei et al., 2008;
Leboucher et al., 2012
(Continued on next page)
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Table 1. Continued
Protein Interactor Function Redox Modification Reference
Parkin Mfns E3 ubiquitin ligase for Mfns.
PINK1 phosphorylates Mfn2
and promotes its Parkin-mediated
ubiquitination and breakdown.
S-nitrosylation inhibits Parkin’s ubiquitin
E3 ligase activity. This could inhibit
Parkin-mediated Mfn breakdown and
stimulate mitochondrial filamentation.
Chung et al., 2004;
Glauser et al., 2011;
Chen and Dorn, 2013
PKA Mfn2 Mfn2 is an important suppressor
of vascular smooth muscle cell
proliferation. PKA phosphorylation
at Ser442 suppresses growth
independent of Mfn2
morphology effects.
Disulfide bond (regulatory a and b subunit)
and nitration (regulatory b subunit). Formation
of a disulfide bond between the two regulatory
subunits of PKA induces activation.
Brennan et al., 2006;
Zhou et al., 2010
Databases used: HGNC (HUGO Gene Nomenclature Committee) database of human gene names (http://www.genenames.org), HPRD (Human Pro-
tein Reference Database, http://www.hprd.org), SNObase (S-Nitrosylation database, http://www.nitrosation.org), UnitprotKB (only reviewed protein
entries were included, http://www.uniprot.org), STRING (Search Tool for the Retrieval of Interacting Genes/Proteins, http://string-db.org), MINT (the
Molecular INTeraction database, http://mint.bio.uniroma2.it/mint/Welcome.do). For abbreviations, see Supplemental Information.
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ROMO1 can be inactivated in an oxidizing environment by for-
mation of an intermolecular disulfide bond causing oligomeriza-
tion. This inactivation is GSH dependent and paralleled by
reduced mitochondrial fusion, OPA1 cleavage, impairment of
OPA1 oligomerization, and cristae shape alterations. It was
proposed that ROMO1 might mediate the coupling between
mitochondrial ROS levels, OPA1 oligomerization, and cristae
junction integrity (Norton et al., 2014).
Redox Regulation of Mfns
Mfn2 is phosphorylated at Ser27 by c-Jun N-terminal kinase
(JNK), which leads to recruitment of the ubiquitin ligase (E3)
Huwe1/Mule/ARF-BP1/HectH9/E3Histone/Lasu1 to Mfn2 (Leb-
oucher et al., 2012). As a consequence Mfn2 is ubiquitinated
and subsequently degraded, leading to mitochondrial fragmen-
tation and apoptotic cell death. Activity of JNK1 and JNK3 is
inhibited by S-nitrosylation (Park et al., 2000), providing a mech-
anism to prevent Mfn2 ubiquitination and mitochondrial frag-
mentation. Enigmatically, exogenously added NOd appears to
inhibit the S-nitrosylation of JNK3 induced by endogenous
NOd during cerebral ischemia and reperfusion in rat hippocam-
pus (Pei et al., 2008). In addition to Drp1 (see above), Parkin
also acts as an E3 ubiquitin ligase for Mfn1 (Glauser et al.,
2011). PINK1 phosphorylates Mfn2 and promotes its Parkin-
mediated ubiquitination and breakdown (Chen and Dorn,2013). S-nitrosylation inhibits Parkin’s ubiquitin E3 ligase activity
(Chung et al., 2004), which could inhibit Parkin-mediated
Mfn1 breakdown and stimulate mitochondrial filamentation.
This might provide a mechanism for RNS-induced stimulation
of mitochondrial filamentation. PKA can be activated by disulfide
bond formation (see above) and phosphorylates Mfn2 at Ser422.
However, this phosphorylation appears not to affect mitochon-
drial morphology (Zhou et al., 2010).
Other Links between Redox State and Mitochondrial
Morphology
Mitochondrial lipids like diacylglycerol (DAG), phosphatidyletha-
nolamine (PE), phosphatidic acid (PA), and cardiolipin (CL) play
an important role in mitochondrial morphology regulation
(reviewed in Ha and Frohman, 2014). Peroxidation of CL is cata-
lyzed by a CL-specific peroxidase of CL-bound cytochrome
c (cyt-c; which shuttles protons from CIII to CIV; Kagan et al.,
2005). CL peroxidation is essential for the release of pro-
apoptotic factors from mitochondria into the cytosol (see Ren
et al., 2014 and the references therein). With respect to mito-
chondrial morphology, evidence in yeast demonstrated that
CL plays a role in the recruitment to mitochondria of fusion-
and fission-promoting proteins (see Ha and Frohman, 2014
and the references therein). dOH-induced peroxidation and
carbonylation of MIM lipids and proteins, respectively, was
linked to Dc depolarization (Iqbal and Hood, 2014). The latterFigure 3. Non-transcriptional Pathways
Linking Redox Homeostasis to
Mitochondrial Fission and Fusion
Mitochondria are exposed to superoxide (O2d
)
and nitric oxide (NOd) that are converted into
hydrogen peroxide (H2O2) and peroxinitrite
(ONOO). Current literature and database analysis
highlighted that these reactive species can induce
nitration (green), S-nitrosylation (SNO; red) or
affect disulfide bonds (S-S; blue). Drp1 and OPA1
(aswell as proteinaceous binding partners of Drp1,
OPA1, and Mfn2) are direct targets of these
modifications, inducing functional alterations.
Depolarization of Dc induced by the hydroxyl
radical (dOH) was demonstrated to functionally
affect OPA1 cleavage and thereby its function.
Abbreviations and literature references are pro-
vided in the Supplemental Information.
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Figure 4. Interaction between
Mitochondrial Dynamics, Redox
Homeostasis, and Function
Working model linking mitochondrial morphology,
ROS/RNSproduction, and functional state (arrows
a–e) in an interacting mechanism (Homeostatic
circuit I). This circuit allows ROS/RNS signaling
and is augmented by two additional mechanisms
that suppress ROS/RNS levels (Homeostatic
circuit II) and oxidative stress (Homeostatic
circuit III). ROS/RNS from the cytosol, endoge-
nous antioxidants, and various other parameters
(lower box) exert a modulating effect on this sys-
tem (see Regulation of Mitochondrial Morphology
by Cellular Redox State for further details).
Cell Metabolism
PerspectiveaffectsDc-dependent OPA1 processing/function andmitochon-
drial morphology (Guillery et al., 2008).
Regulation of Mitochondrial Morphology by Cellular
Redox State
Although the field is still at an early stage, we hypothesize
here that mitochondrial morphology, redox homeostasis, and
morphology are bi-directionally linked (Figure 4; arrows a–f).
The main ROS/RNS involved in this system are H2O2, NO
d,
and ONOO. With respect to reactivity, dOH reacts very fast
with virtually all biomolecules, whereas other ROS such as
O2
d, H2O2, and NOd are more selective, or display intermediate
reactivity (ONOO; Halliwell and Gutteridge, 2012). This chemi-
cal reactivity allows mitochondria-generated dOH and O2
d to
act more locally, whereas H2O2 and NO
d can function as both
a cytosolic and extracellular messenger, which generally induce
reversible and irreversible atomic modifications at low and high
levels, respectively (Winterbourn, 2008). Non-transcriptional
regulation of mitochondrial fission/fusion proteins by ROS and
RNS might provide the cell with a homeostatic mechanism
(Figure 4; homeostatic circuit I) that sustains proper mitochon-
drial morphology, function, and redox homeostasis. It is highly
likely that the balance between these entities depends on the
cell type and experimental context. As a second line of defense
against oxidative stress, it has been proposed that a mild
increase in mitochondrial ROS production induces activation
of long-lasting cytoprotective pathways by nuclear transcrip-
tional changes. This process of ‘‘mitohormesis’’ is thought to
protect cells against subsequent stress-inducing events (Yun
and Finkel, 2014) and includes upregulation of endogenous anti-
oxidant enzymes that maintain redox homeostasis (homeostatic
circuit II) and avoid oxidative stress by reversing or preventing
oxidative modification of DNA, proteins, and lipids (homeostatic
circuit III). In this mechanism ROS/RNS generated outside the214 Cell Metabolism 22, August 4, 2015 ª2015 Elsevier Inc.mitochondrion can modulate homeo-
static circuit I to exert control or trigger
oxidative stress. Similarly, the properties
of this circuit are influenced by various
other parameters including substrate
availability, oxygen pressure, environ-
mental toxins, and/or the presence of
pathogenic mutations (Figure 4). Mito-
chondrial fragmentation has been linked
to mitochondrial inheritance during celldivision and apoptosis and appears to be required for removal
of dysfunctional mitochondria by (ROS-induced) mitophagy
(Arnoult et al., 2005; Twig and Shirihai, 2011; Frank et al.,
2012; Picard et al., 2013; Mishra and Chan, 2014). A fragmented
mitochondrial phenotype is often observed during pathophysio-
logical conditions in humans including PD/AD, Huntington’s
disease, ischemia/reperfusion injury, drug-induced tissue dam-
age, and inherited mitochondrial metabolic disorders (Archer,
2013). This suggests that reversal of mitochondrial fragmenta-
tion, possibly by genetic or pharmacological modulation of
endogenous antioxidant levels or application of cell-permeable
exogenous antioxidants (Figure 4), could be a valid therapeutic
strategy in human disease (e.g., Koopman et al., 2007; Lackner
and Nunnari, 2010; Blanchet et al., 2011, 2015; Distelmaier
et al., 2012; Archer, 2013; Guo et al., 2013; Reddy, 2014). How-
ever, for such strategies to be successful, a detailed understand-
ing of the various homeostatic circuits is required. In this respect,
we expect that application of targeted (anti)oxidants, (targeted)
ROS-generating molecules, and (targeted) ROS/RNS reporter
molecules will be of great value to assess and modulate the
levels of (local) ROS/RNS and their downstream effects (Skula-
chev, 2005; Forkink et al., 2010, 2014; Cocheme´ et al., 2011;
Smith et al., 2011; Prime et al., 2012).
Conclusion
Accumulating evidence suggests that cellular and mitochondrial
redox homeostasis is linked to mitochondrial dynamics in a cell-
and tissue-dependent manner. During healthy and pathological
conditions, mitochondria generate ROS and are exposed
to RNS, which act as signaling and/or damaging molecules.
Here we propose that (local) ROS and/or RNS regulate mito-
chondrial dynamics through acting on mitochondrial fusion and
fission proteins. This would permit (auto)regulation of mitochon-
drial morphology and function by redox-mediated signaling.
Cell Metabolism
PerspectiveUnderstanding this mechanism is crucial to unravel the patho-
logical events in themany human disorders where redox homeo-
stasis, mitochondrial function, and structure are disturbed, as
well as to develop successful rational intervention strategies.
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